Annual Net Income
-$153.61 M
+$496.56 M+76.37%
31 December 2023
Summary:
CRISPR Therapeutics AG annual net profit is currently -$153.61 million, with the most recent change of +$496.56 million (+76.37%) on 31 December 2023. During the last 3 years, it has risen by +$195.25 million (+55.97%). CRSP annual net income is now -140.67% below its all-time high of $377.66 million, reached on 31 December 2021.CRSP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$85.94 M
+$40.47 M+32.01%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly net profit is currently -$85.94 million, with the most recent change of +$40.47 million (+32.01%) on 30 September 2024. Over the past year, it has increased by +$26.21 million (+23.37%). CRSP quarterly net income is now -111.32% below its all-time high of $759.23 million, reached on 30 June 2021.CRSP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$239.59 M
+$26.21 M+9.86%
30 September 2024
Summary:
CRISPR Therapeutics AG TTM net profit is currently -$239.59 million, with the most recent change of +$26.21 million (+9.86%) on 30 September 2024. Over the past year, it has increased by +$113.94 million (+32.23%). CRSP TTM net income is now -153.65% below its all-time high of $446.58 million, reached on 30 June 2021.CRSP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.4% | +23.4% | +32.2% |
| 3 y3 years | +56.0% | +32.4% | -158.2% |
| 5 y5 years | +6.9% | -162.1% | -2025.2% |
CRSP Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -140.7% | +76.4% | -196.2% | +53.8% | -158.2% | +64.8% |
| 5 y | 5 years | -140.7% | +76.4% | -111.3% | +53.8% | -153.7% | +64.8% |
| alltime | all time | -140.7% | +76.4% | -111.3% | +53.8% | -153.7% | +64.8% |
CRISPR Therapeutics AG Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$85.94 M(-32.0%) | -$239.59 M(-9.9%) |
| June 2024 | - | -$126.41 M(+8.4%) | -$265.80 M(+22.4%) |
| Mar 2024 | - | -$116.59 M(-230.5%) | -$217.14 M(+41.4%) |
| Dec 2023 | -$153.61 M(-76.4%) | $89.35 M(-179.7%) | -$153.61 M(-56.5%) |
| Sept 2023 | - | -$112.15 M(+44.3%) | -$353.53 M(-15.0%) |
| June 2023 | - | -$77.74 M(+46.5%) | -$415.93 M(-20.6%) |
| Mar 2023 | - | -$53.06 M(-52.0%) | -$524.02 M(-19.4%) |
| Dec 2022 | -$650.17 M(-272.2%) | -$110.58 M(-36.7%) | -$650.17 M(-4.5%) |
| Sept 2022 | - | -$174.55 M(-6.1%) | -$680.85 M(+7.5%) |
| June 2022 | - | -$185.83 M(+3.7%) | -$633.45 M(-303.3%) |
| Mar 2022 | - | -$179.22 M(+26.9%) | $311.61 M(-17.5%) |
| Dec 2021 | $377.66 M(-208.3%) | -$141.25 M(+11.1%) | $377.66 M(-8.3%) |
| Sept 2021 | - | -$127.15 M(-116.7%) | $411.87 M(-7.8%) |
| June 2021 | - | $759.23 M(-770.9%) | $446.58 M(-213.8%) |
| Mar 2021 | - | -$113.16 M(+5.7%) | -$392.30 M(+12.4%) |
| Dec 2020 | -$348.87 M(-621.8%) | -$107.04 M(+15.8%) | -$348.87 M(+65.1%) |
| Sept 2020 | - | -$92.44 M(+16.0%) | -$211.28 M(-1179.2%) |
| June 2020 | - | -$79.66 M(+14.2%) | $19.58 M(-57.0%) |
| Mar 2020 | - | -$69.73 M(-328.3%) | $45.53 M(-31.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $66.86 M(-140.5%) | $30.54 M(-77.9%) | $66.86 M(-693.0%) |
| Sept 2019 | - | $138.42 M(-357.8%) | -$11.27 M(-94.4%) |
| June 2019 | - | -$53.70 M(+10.9%) | -$200.41 M(+8.3%) |
| Mar 2019 | - | -$48.41 M(+1.7%) | -$185.09 M(+12.2%) |
| Dec 2018 | -$164.98 M(+141.4%) | -$47.59 M(-6.2%) | -$164.98 M(+40.7%) |
| Sept 2018 | - | -$50.71 M(+32.1%) | -$117.25 M(+28.5%) |
| June 2018 | - | -$38.38 M(+35.6%) | -$91.25 M(+21.4%) |
| Mar 2018 | - | -$28.30 M(<-9900.0%) | -$75.18 M(+10.0%) |
| Dec 2017 | -$68.36 M(+194.6%) | $141.00 K(-100.6%) | -$68.36 M(+33.0%) |
| Sept 2017 | - | -$24.71 M(+10.7%) | -$51.40 M(+24.2%) |
| June 2017 | - | -$22.32 M(+3.9%) | -$41.39 M(+14.2%) |
| Mar 2017 | - | -$21.48 M(-225.6%) | -$36.23 M(+56.2%) |
| Dec 2016 | -$23.20 M(-10.2%) | $17.10 M(-216.4%) | -$23.20 M(-55.9%) |
| Sept 2016 | - | -$14.69 M(-14.4%) | -$52.59 M(+18.8%) |
| June 2016 | - | -$17.16 M(+103.3%) | -$44.25 M(+63.4%) |
| Mar 2016 | - | -$8.44 M(-31.3%) | -$27.08 M(+45.3%) |
| Dec 2015 | -$25.83 M(+279.8%) | -$12.29 M(+93.4%) | -$18.64 M(+193.4%) |
| Sept 2015 | - | -$6.35 M | -$6.35 M |
| Dec 2014 | -$6.80 M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual net profit?
- What is the all time high annual net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual net income year-on-year change?
- What is CRISPR Therapeutics AG quarterly net profit?
- What is the all time high quarterly net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly net income year-on-year change?
- What is CRISPR Therapeutics AG TTM net profit?
- What is the all time high TTM net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM net income year-on-year change?
What is CRISPR Therapeutics AG annual net profit?
The current annual net income of CRSP is -$153.61 M
What is the all time high annual net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual net profit is $377.66 M
What is CRISPR Therapeutics AG annual net income year-on-year change?
Over the past year, CRSP annual net profit has changed by +$496.56 M (+76.37%)
What is CRISPR Therapeutics AG quarterly net profit?
The current quarterly net income of CRSP is -$85.94 M
What is the all time high quarterly net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly net profit is $759.23 M
What is CRISPR Therapeutics AG quarterly net income year-on-year change?
Over the past year, CRSP quarterly net profit has changed by +$26.21 M (+23.37%)
What is CRISPR Therapeutics AG TTM net profit?
The current TTM net income of CRSP is -$239.59 M
What is the all time high TTM net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM net profit is $446.58 M
What is CRISPR Therapeutics AG TTM net income year-on-year change?
Over the past year, CRSP TTM net profit has changed by +$113.94 M (+32.23%)